Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical atorvastatin/cholesterol and oxiconazole for disorders of cholesterol biosynthesis and keratinization
jRCTs031180409Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atorvastatin, cholesterol emulsion and oxiconazole in Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects (CHILD), Conradi-Hünermann-Happle syndrome (CDPX2), porokeratosis and 3 more (2 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Improvement of skin erythema and scales. Started Dec 2013; status: completed.
02
Drugs
atorvastatincholesterol emulsionoxiconazole
03
Conditions
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects (CHILD)Conradi-Hünermann-Happle syndrome (CDPX2)porokeratosisatopic dermatitis (AD)plaque psoriasis
Beyond the preview
Go deeper on jRCTs031180409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180409.